DUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.
Olivia,
Actual DUPIXENT patient
since 2020.
Individual results may vary.
DUPIXENT works under the skin, continuously treating eczema—even between flare-ups.
A healthy immune
system produces little
to no inflammation on
the skin.
Itching, rashes, and
eczema flare-ups can
happen because your
immune system is
overactive and
overreacting to even
small triggers.
DUPIXENT proactively targets a source of underlying inflammation in your body that causes itching and rashes on the surface of your skin.
Actual real-world DUPIXENT adult patient; not a clinical trial patient. Additional factors (including possible use of
other treatments) may have impacted results. Individual results may vary.
Actual 12-year-old clinical trial patient treated with DUPIXENT. This patient did not meet clinical trial criteria
for clear or almost clear skin at 16 weeks. Individual results may vary.
Actual 10-year-old clinical trial patient treated with DUPIXENT and a topical corticosteroid. This patient met
clinical trial criteria for clear or almost clear skin. Individual results may vary.
Actual 4-year-old clinical trial patient treated with DUPIXENT and a topical corticosteroid. This patient met
clinical trial criteria for clear or almost clear skin. Individual results may vary.
*Adults take DUPIXENT every 2 weeks. Certain children may be eligible to take DUPIXENT once every 4 weeks. See Dosing Page for more information.
Find easy access to important information about DUPIXENT
